# Moderna, Inc.: Form 8-K, filed Sep 12, 2024

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2024-09-12
- Accepted by EDGAR: Sep 12, 2024, 06:03 ET
- Period: 2024-09-12
- Accession: 0001682852-24-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000049/mrna-20240912.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000049/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000168285224000049/mrna-20240912.htm

Filed Sep 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001682852-24-000049. Last ingested by Listed: Nov 10, 2026, 03:22 ET. No prices; not investment advice.